Skip to main content
logo
WORK Medical Technology Group LTD (WOK)
NASDAQ: WOK · Real-Time Price · USD
2.330
-0.020 (-0.85%)
At close: Aug 28, 2026, 4:00 PM EDT
2.280
-0.050 (-2.15%)
After-hours: Aug 28, 2026, 7:58 PM EDT

WOK Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
10.729.8511.5113.5719.7145.86
Revenue Growth
-0.21%-14.41%-15.18%-31.18%-57.02%-12.68%
Cost of Revenue
8.97.58.649.4215.2937.22
Gross Profit
1.822.342.874.144.428.64
Selling, General & Admin
64.416.613.433.64.49
Research & Development
0.280.440.30.30.180.19
Operating Expenses
6.294.846.913.733.784.67
Operating Income
-4.47-2.5-4.050.410.643.97
Interest Expense
-0.33-0.5-0.56-0.39-0.35-0.33
Interest & Investment Income
0.210.180.010.030-
Other Non Operating Income (Expenses)
0.121.740.930.071.190.1
EBT Excluding Unusual Items
-4.42-1.08-3.670.111.473.74
Gain (Loss) on Sale of Assets
-----0.36-
Other Unusual Items
-----3.61
Pretax Income
-4.42-1.08-3.670.111.117.34
Income Tax Expense
0.210.12-0.130.050.171.08
Earnings From Continuing Operations
-4.63-1.2-3.540.060.946.27
Minority Interest in Earnings
0.140.130.050.05-0.08-0.31
Net Income
-4.5-1.07-3.490.110.875.96
Net Income to Common
-4.5-1.07-3.490.110.875.96
Net Income Growth
----87.05%-85.48%411.91%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
-5.624.91-11.451.75-4.27-7.24
Gross Margin
16.97%23.81%24.93%30.54%22.42%18.84%
Operating Margin
-41.68%-25.34%-35.16%3.04%3.24%8.65%
Profit Margin
-41.95%-10.89%-30.35%0.83%4.39%12.99%
Free Cash Flow Margin
-52.48%49.87%-99.54%12.93%-21.67%-15.78%
EBITDA
-3.37-1.57-2.632.023.98.16
EBITDA Margin
-31.44%-15.97%-22.90%14.86%19.77%17.79%
D&A For EBITDA
1.10.921.411.63.264.19
EBIT
-4.47-2.5-4.050.410.643.97
EBIT Margin
-41.68%-25.34%-35.16%3.04%3.24%8.65%
Effective Tax Rate
---42.58%15.22%14.69%
SEC Filings: 10-K · 10-Q